Gabawin-ER 82.5 Tablet
By Gabawin
Rx
10 Tablet ER in a Strip

Composition
Pregabalin(82.5mg)

Manufacturer - Icon Life Sciences
Icon Life Sciences, Div. Of Mesmer Pharmaceuticals, No.202/6, Lane In.30, Phase-II, IDA, Cherlapally, Hyderabad, 500 051 AP

Expires on or after
April, 2026

liver
When it comes to the safety of Gabawin-ER 82.5 Tablet in relation to liver conditions, it is important to note that this medication is considered safe for use in patients with liver disease. It is reassuring to know that no dose adjustment of Gabawin-ER 82.5 Tablet is necessary in such cases. This means that individuals with liver issues can typically take this medication without concerns about dosage modifications. This information offers peace of mind for those managing liver conditions and needing treatment with Gabawin-ER 82.5 Tablet.

kidney
Gabawin-ER 82.5 Tablet requires caution in patients with kidney disease. Adjustments to the dosage may be necessary. Consult your doctor for guidance.

alcohol
When consuming alcohol while taking Gabawin-ER 82.5 Tablet, be aware that it can lead to increased drowsiness.

driving
When taking Gabawin-ER 82.5 Tablet, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Gabawin-ER 82.5 Tablet may not be safe for use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. It is important to consult your doctor regarding its use in pregnancy.

breastfeeding
Gabawin-ER 82.5 Tablet is likely unsafe during breastfeeding, as limited human data indicates it might pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Cyclic GABA Analogues |
Therapeutic Class | NEURO CNS |
Action Class | Alpha 2 delta ligands (AED) |
₹224
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024